MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Cardiovascular
  • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • Videos
    • Whitepapers
  • DeviceTalks

Biotech, pharma chime in over Trump’s move to halt immigration program

September 6, 2017 By Sarah Faulkner Leave a Comment

On Tuesday, biotech and pharmaceutical companies urged president Donald Trump to reconsider his decision to end former president Barack Obama’s policy protecting undocumented immigrants who arrived in the U.S. as children. Attorney general Jeff Sessions said Tuesday morning that Trump would move to halt the Deferred Action for Childhood Arrivals program in six months, unless […]

Filed Under: Biotech, Legal News, Pharmaceutical, Wall Street Beat Tagged With: Acorda Therapeutics, Alnylam Pharmaceuticals Inc., Bigfoot Biomedical, Biogen, decibeltherapeutics, Juno Therapeutics, ovidtherapeutics

Alnylam, The Medicines Co., detail Phase III trial for RNA-based heart drug

April 26, 2017 By Sarah Faulkner Leave a Comment

The Medicines Co. (NSDQ:MDCO) and Alnylam Pharmaceuticals (NSDQ:ALNY) said today that they’ve reached a deal with the FDA over a Phase III trial for the companies’ RNA-based cholesterol-lowering drug, inclisiran. If approved, it would be the 1st RNA-interference therapy on the market. The drug is a part of a new group of drugs called PCSK9 […]

Filed Under: Cardiovascular, Clinical Trials, Food & Drug Administration (FDA), Wall Street Beat Tagged With: Alnylam Pharmaceuticals Inc., Amgen, Regeneron, The Medicines Co.

Acuitas touts lipid-nanoparticle delivery of mRNA vaccine for Zika

February 3, 2017 By Sarah Faulkner Leave a Comment

Acuitas Therapeutics touted preliminary data that evaluated its messenger RNA vaccine for the Zika virus. The company uses a lipid-nanoparticle delivery system to introduce its mRNA vaccine into cells. The team’s work, which was published in Nature, showed that a single low-dose immunization with its vaccine triggered an immune response in animals and protected them from infection at […]

Filed Under: Drug-Device Combinations, Research & Development Tagged With: Acuitas Therapeutics, Alnylam Pharmaceuticals Inc., University of Pennsylvania

Codiak BioSciences lures Alnylam vet Sorensen to lead clinical program

October 13, 2016 By Sarah Faulkner Leave a Comment

Codiak BioSciences said today that it has named former Alnylam Pharmaceuticals (NSDQ:ALNY) executive Dr. Benny Sorensen as vice president and head of clinical development. Sorensen was Alnylam’s senior director of clinical research, leading the preclinical, clinical, regulatory and commercial strategies for hematology products. He also worked for Baxter (NYSE:BAX), advancing hematology therapies through Phase III pivotal development. Get the […]

Filed Under: Drug-Device Combinations Tagged With: Alnylam Pharmaceuticals Inc., Codiak BioSciences

Entegrion licenses clotting bandage to Boston device firm

April 20, 2011 By MedCity News Leave a Comment

Entegrion

For its 9th birthday, the biotech Entegrion is giving itself a present: a product on the market.

The Research Triangle Park, N.C.-based company struck a licensing deal with a Boston-based medical device company to manufacture and market Entegrion’s Stasilon bandage: a proprietary weave of glass and bamboo fibers that promotes clotting. CTO Joseph DaCorta wouldn’t name the company Beantown partner, but DaCorta did say that the business expects to make an announcement this week.

Filed Under: News Well Tagged With: Alnylam Pharmaceuticals Inc., Distribution, Entegrion Inc., GE Healthcare, Precision NanoSystems Inc., RTI Surgical, Vystar Corp.

Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Popular Posts

  • Report: SEC probes GE Healthcare, Philips, Siemens in Chinese bribery scheme
  • Edwards Lifesciences warns against below-market mini-tender offer Edwards Lifesciences
  • J&J’s Ethicon files ITC complaint against Intuitive Surgical Intuitive Surgical's EndoWrist instruments
  • Auris Health loses motion to move Intuitive Surgical patent suit from Del. to Cali. Johnson & Johnson's Auris, Intuitive Surgical
  • Enable Injections inks deal with Sanofi for drug delivery platform enfuse-enable-injections
Tweets by @MassDevice
MDO ad

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us
Add us on FacebookMassDevice Network
Follow us on Twitter@MassDevice
Connect with us on LinkedInLinkedIn
Follow us on YouTube YouTube

Copyright © 2019 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS